Patents have already been granted on many of the products and processes involved in synthetic biology.
Examples include
• Patents on methods of building synthetic DNA strands (US 6,521,427, “Method for the complete chemical synthesis and assembly of genes and genomes,” assigned to Egea Biosciences, a subsidiary of Johnson & Johnson)
• Patents on synthetic cell machinery such as modified ribosomes (WIPO Patent WO05123766A2: “Methods
Of Making Nanotechnological And Macromolecular Biomimetic Structures,” awarded to Alexander Sunguroff)
• Patents on genes or parts of genes represented by their sequencing information (“DNA and Patent Law,” on the Internet: http://www.thebiotechclub.org/industry/ articles/dnapatentlaw.php)
• Patents for the engineering of biosynthetic pathways (WIPO Patent WO05033287A3: “Methods For Identifying A Biosynthetic Pathway Gene Product” claimed by The Regents of the University of California, or US20060079476A1, US patent application entitled, “Method for enhancing production of isoprenoid compounds.”)
• Patents on new and existing proteins and amino acids (WIPO Patent WO06091231A2: “Biosynthetic Polypeptides Utilizing Non-Naturally Encoded Amino Acids” (2006) awarded to Ambrx, Inc)
• Patents on novel nucleotides that augment and replace the letters of DNA (US 5,126,439, “Artificial DNA base pair analogues,” awarded to Harry P. Rappaport; and S.Benner, US Patent 6,617,106, “Methods for preparing oligonucleotides containing non-standard nucleotides.”)
Examples include
• Patents on methods of building synthetic DNA strands (US 6,521,427, “Method for the complete chemical synthesis and assembly of genes and genomes,” assigned to Egea Biosciences, a subsidiary of Johnson & Johnson)
• Patents on synthetic cell machinery such as modified ribosomes (WIPO Patent WO05123766A2: “Methods
Of Making Nanotechnological And Macromolecular Biomimetic Structures,” awarded to Alexander Sunguroff)
• Patents on genes or parts of genes represented by their sequencing information (“DNA and Patent Law,” on the Internet: http://www.thebiotechclub.org/industry/ articles/dnapatentlaw.php)
• Patents for the engineering of biosynthetic pathways (WIPO Patent WO05033287A3: “Methods For Identifying A Biosynthetic Pathway Gene Product” claimed by The Regents of the University of California, or US20060079476A1, US patent application entitled, “Method for enhancing production of isoprenoid compounds.”)
• Patents on new and existing proteins and amino acids (WIPO Patent WO06091231A2: “Biosynthetic Polypeptides Utilizing Non-Naturally Encoded Amino Acids” (2006) awarded to Ambrx, Inc)
• Patents on novel nucleotides that augment and replace the letters of DNA (US 5,126,439, “Artificial DNA base pair analogues,” awarded to Harry P. Rappaport; and S.Benner, US Patent 6,617,106, “Methods for preparing oligonucleotides containing non-standard nucleotides.”)
No comments:
Post a Comment